These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 28595078)

  • 1. Amyloidogenic proteins associated with neurodegenerative diseases activate the NLRP3 inflammasome.
    Shao QH; Zhang XL; Yang PF; Yuan YH; Chen NH
    Int Immunopharmacol; 2017 Aug; 49():155-160. PubMed ID: 28595078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammasome activation in neurodegenerative diseases.
    Ravichandran KA; Heneka MT
    Essays Biochem; 2021 Dec; 65(7):885-904. PubMed ID: 34846519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective.
    Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Papadakis M; Jabir MS; Saad HM; Batiha GE
    J Cell Mol Med; 2023 Jul; 27(13):1775-1789. PubMed ID: 37210624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of NLRP3 Inflammasome in Parkinson's Disease and Therapeutic Considerations.
    Nguyen LTN; Nguyen HD; Kim YJ; Nguyen TT; Lai TT; Lee YK; Ma HI; Kim YE
    J Parkinsons Dis; 2022; 12(7):2117-2133. PubMed ID: 35988226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases.
    Wu AG; Zhou XG; Qiao G; Yu L; Tang Y; Yan L; Qiu WQ; Pan R; Yu CL; Law BY; Qin DL; Wu JM
    Ageing Res Rev; 2021 Jan; 65():101202. PubMed ID: 33161129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer's and Parkinson's Disease.
    Lee JH; Kim HJ; Kim JU; Yook TH; Kim KH; Lee JY; Yang G
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease.
    Li Y; Xia Y; Yin S; Wan F; Hu J; Kou L; Sun Y; Wu J; Zhou Q; Huang J; Xiong N; Wang T
    Front Immunol; 2021; 12():719807. PubMed ID: 34691027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of the Inflammasome in Neurodegenerative Diseases.
    Piancone F; La Rosa F; Marventano I; Saresella M; Clerici M
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33670164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases.
    Possemato E; La Barbera L; Nobili A; Krashia P; D'Amelio M
    Ageing Res Rev; 2023 Jun; 87():101907. PubMed ID: 36893920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases.
    Feng YS; Tan ZX; Wu LY; Dong F; Zhang F
    Biomed Pharmacother; 2021 Jun; 138():111428. PubMed ID: 33667787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders.
    Zhou K; Shi L; Wang Y; Chen S; Zhang J
    J Immunol Res; 2016; 2016():9238290. PubMed ID: 27652274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases.
    Pellegrini C; Fornai M; Antonioli L; Blandizzi C; Calderone V
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31200447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease.
    Wang S; Yuan YH; Chen NH; Wang HB
    Int Immunopharmacol; 2019 Feb; 67():458-464. PubMed ID: 30594776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NLRP3 Inflammasome-Related Proteins Are Upregulated in the Putamen of Patients With Multiple System Atrophy.
    Li F; Ayaki T; Maki T; Sawamoto N; Takahashi R
    J Neuropathol Exp Neurol; 2018 Nov; 77(11):1055-1065. PubMed ID: 30295793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease.
    Zhou Y; Lu M; Du RH; Qiao C; Jiang CY; Zhang KZ; Ding JH; Hu G
    Mol Neurodegener; 2016 Apr; 11():28. PubMed ID: 27084336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLRP3 and Infections: β-Amyloid in Inflammasome beyond Neurodegeneration.
    Sita G; Graziosi A; Hrelia P; Morroni F
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of NLRP3 activation and pathology during neurodegeneration.
    Jose S; Groves NJ; Roper KE; Gordon R
    Int J Biochem Cell Biol; 2022 Oct; 151():106273. PubMed ID: 35926782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRP3 inflammasome in neurodegenerative disease.
    Anderson FL; Biggs KE; Rankin BE; Havrda MC
    Transl Res; 2023 Feb; 252():21-33. PubMed ID: 35952982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of NLRP3 Inflammasome and Its Inhibitors as Emerging Therapeutic Drug Candidate for Alzheimer's Disease: a Review of Mechanism of Activation, Regulation, and Inhibition.
    Sharma B; Satija G; Madan A; Garg M; Alam MM; Shaquiquzzaman M; Khanna S; Tiwari P; Parvez S; Iqubal A; Haque SE; Khan MA
    Inflammation; 2023 Feb; 46(1):56-87. PubMed ID: 36006570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.